ArticleTranslational oncology2021

Survival prediction and response to immune checkpoint inhibitors: A prognostic immune signature for hepatocellular carcinoma.

Ying Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.